×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Ocular Hypertension Market Size and Share to Increase by 2032, Asserts DelveInsight | Leading Companies in the ...
GlobeNewswire
Several approved therapies such as EYBELIS, Durysta, Alphagan-P, Rhopressa, etc. will drive the current therapeutic landscape of ocular...
6 months ago
Hypertension Market to Accelerate Positively, Estimates DelveInsight | Key Companies Active in the Market - Novartis ...
PR Newswire
PRNewswire/ -- DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices,...
10 months ago
Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107
Yahoo Finance
SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC:...
25 months ago
Allogene, Progenity, Adaptive Phage Tout New Top Executives
BioSpace
Published: Apr 29, 2022 By Alex Keown. Business Handshake. Pharma, biotech and life sciences organizations add new leaders to their boards and executive...
24 months ago
Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company's Phase 1 ...
GlobeNewswire
SAN FRANCISCO, CA and TORONTO, ON , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF)...
27 months ago
Scene Health Raises $17.7M To Improve Medication Adherence for Medicaid, Medicare Population
MedCity News
Medication non-adherence costs the U.S. healthcare system more than $500 billion each year and can lead to unnecessary hospitalizations.
13 months ago
Kalytera Therapeutics Offers Alternative To Current Osteoporosis Treatment (OTCMKTS:CLAZF)
Seeking Alpha
Focused on patents that treat, bone fractures, Osteogenesis Imperfecta, Osteoporosis and Osteoporosis in Prader-Willi Syndrome,...
87 months ago
Traumatic Brain Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 ...
Home - GlobalData
Traumatic brain injury happens when an external mechanical force causes brain damage. The traumatic brain injury drugs market report...
25 months ago
Understanding Data Aggregation In The Pharmacy Industry
Forbes
An increasing number of industries are turning to data aggregation and analysis to improve their operations. Data aggregation services are...
70 months ago
Kalytera Therapeutics Inc. Completes Name Change to Claritas Pharmaceuticals, Inc.
GlobeNewswire
Kalytera Therapeutics Inc. Completes Name Change to Claritas Pharmaceuticals, Inc. Company to Hold Annual and Special Meeting on June 17, 2021.
37 months ago